Clearance Summary
The Circadia C300 System (C300) received FDA 510(k) clearance under submission number K252676, sponsored by Circadia Health, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2026-02-03.
- Submission: K252676
- Applicant / Sponsor: Circadia Health, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2300
- Decision date: 2026-02-03
Classification & Regulation
This clearance is catalogued under FDA product code DRT and 21 CFR 870.2300, within the Cardiovascular review panel as a Class II device.